A new study has found that of the over 9,000 different drugs marketed in Canada between 2017 and 2018, nearly 25 per cent were reported in shortage -- including EpiPens and treatments for Parkinson’s disease, epilepsy and depression.
In an unusual trend, it was more likely for a drug to be in shortage if it was produced by a generic company and there was no other competition.
They found that 23.4 per cent were reported in shortage during the study period -- between March 14, 2017 and Sept. 12, 2018. The average length of a shortage was five months. “I was very alarmed when I saw entire markets, all the brand names of a drug were not available and this was causing patients lots of hardship,” said Anis.
“We have to, at times, make patients wait. Sometimes these medications have very profound effects in their life and we just have to make them wait.”Eighty-six-year-old Lois Forrest has severe asthma, and relies on three medications to help her breathe with ease.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Canadian transit ridership dropped nearly 75 per cent in June compared with 2019: StatCanNew data show public transit systems in Canada were still feeling the hit of the COVID-19 pandemic in June, with subway, train and bus trips dropping nearly 75 per cent compared with last year.
Read more »
Canada inks deals with two American suppliers for potential COVID-19 vaccinesTrudeau: \u0027We\u0027re making sure that if one of these potential vaccines is successful, Canada and Canadians will have access to the doses they need\u0027
Read more »
Canada Secures At Least 88M Doses Of Potential COVID-19 VaccinesThe earliest date the vaccines might be ready for widespread use is next spring.
Read more »
Canada signs deals with two suppliers for potential COVID-19 vaccinesPrime Minister Justin Trudeau says the federal government has signed agreements with two more American suppliers to reserve millions of doses of their experimental COVID-19 vaccines for Canadians.
Read more »
Canada to buy up to 76 million doses of Novavax’s potential coronavirus vaccineThe deal is the latest example of countries rushing to secure access to vaccines, and comes weeks after Canada signed separate deals with Pfizer and Moderna
Read more »